Sector Details:Medical

Medical : News and Opinion

Mylan (MYL) PT Lifted To $26 By RBC Capital On Positive Developments, 'Outperform' Maintained

May 16, 2012

RBC Capital Markets analyst Shibani Malhotra increased her price target on shares of Mylan Inc. (NASDAQ:MYL) to $26 from $25 on recent positive developments, while maintaining "Outperform" rating. read on...

Baxter (BAX): ADVATE Approved In China To Treat Blood Clotting Disorder

May 16, 2012

Baxter International Inc. (NYSE:BAX) said ADVATE (Recombinant Human Coagulation Factor VIII for injection) for the treatment of hemophilia A was approved in China by the State Food and Drug Administration (SFDA). read on...

Cepheid (CPHD) Upgraded To 'Buy' By UBS Securities, PT Lifted To $45

May 15, 2012

UBS Securities analyst Daniel Arias upgraded his rating on shares of Cepheid (NASDAQ:CPHD) to "Buy" from "Neutral" and increased his price target to $45 from $44, saying recent decline offers buying opportunity for the company's stock. read on...

Galectin Therapeutics (GALT) Starts Phase 1/2 Combination Trial For Advanced Metastatic Melanoma

May 15, 2012

Galectin Therapeutics Inc. (NASDAQ:GALT) said the first patient has been dosed in a Phase 1/2 trial evaluating the safety and efficacy of a novel treatment combination for the treatment of advanced metastatic melanoma. read on...

Bristol Myers Squibb (BMY): FDA Approves Devens Biologics Facility For Orencia Production

May 15, 2012

Bristol Myers Squibb Co. (NYSE:BMY) said the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial production of arthritis treatment Orencia (abatacept). read on...

Boston Scientific (BSX): Trial Suggests Lotus Aortic Valve System Minimizes Aortic Regurgitation

Boston Scientific Corp. (NYSE:BSX) said the results of REPRISE 1 feasibility trial suggest the Lotus Aortic read on...

Nymox Pharmaceutical (NYMX) Posts Narrower Q1 Loss

Nymox Pharmaceutical Corp. (NASDAQ:NYMX), a biopharmaceutical company, reported a narrower loss for the read on...

Achillion Pharma (ACHN) Gets Fast Track Designation From FDA To Treat Chronic Hepatitis C

Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) said it received a Fast Track designation from the U.S. Food read on...

Opko Health (OPK) Gets U.S. Patent Allowance For Flow Control In Microfluidic Systems

Opko Health Inc. (NYSE:OPK) said it received a patent allowance from the U.S. Patent and Trademark Office read on...

Medical Articles

Mylan (MYL) PT Lifted To $26 By RBC Capital On Positive Developments, 'Outperform' Maintained
By: iStockAnalyst
Publish Date: Wednesday, May 16, 2012
Stocks(s): MYL

J.C. Penney Co. Options Active After Earnings Disappoint
By: Andrew Wilkinson
Publish Date: Wednesday, May 16, 2012
Stocks(s): GS, JCP, OSUR

Baxter (BAX): ADVATE Approved In China To Treat Blood Clotting Disorder
By: iStockAnalyst
Publish Date: Wednesday, May 16, 2012
Stocks(s): BAX

Cerner: 'Riding The Wave' In Healthcare
By: TheStockAdvisors.com
Publish Date: Wednesday, May 16, 2012
Stocks(s): CERN

Capitulation Low...Not In Yet
By: Harry Boxer
Publish Date: Tuesday, May 15, 2012
Stocks(s): AMLN, CGI, DKS, GLUU, NDX, NDY, OPNT, PATK

Cepheid (CPHD) Upgraded To 'Buy' By UBS Securities, PT Lifted To $45
By: iStockAnalyst
Publish Date: Tuesday, May 15, 2012
Stocks(s): CPHD

Galectin Therapeutics (GALT) Starts Phase 1/2 Combination Trial For Advanced Metastatic Melanoma
By: iStockAnalyst
Publish Date: Tuesday, May 15, 2012
Stocks(s): GALT

Warning Signs Of An Imminent Dividend Cut
By: Dividends4Life
Publish Date: Tuesday, May 15, 2012
Stocks(s): BAC, BBI, CTL, EQ, GCI, GE, MXM, PBI

High Yield Momentum Stock Portfolio, May Update
By: Scott's Investments
Publish Date: Tuesday, May 15, 2012
Stocks(s): CINF, CMS, FII, GCI, HCBK, HCN, HCP, HRB

Trading Ideas: Investors To Get Fat Profits From Obesity Drugs
By: iStockAnalyst
Publish Date: Tuesday, May 15, 2012
Stocks(s): ARNA, VVUS

Bristol Myers Squibb (BMY): FDA Approves Devens Biologics Facility For Orencia Production
By: iStockAnalyst
Publish Date: Tuesday, May 15, 2012
Stocks(s): BMY

Boston Scientific (BSX): Trial Suggests Lotus Aortic Valve System Minimizes Aortic Regurgitation
By: iStockAnalyst
Publish Date: Tuesday, May 15, 2012
Stocks(s): BSX

Nymox Pharmaceutical (NYMX) Posts Narrower Q1 Loss
By: iStockAnalyst
Publish Date: Tuesday, May 15, 2012
Stocks(s): NYMX

Achillion Pharma (ACHN) Gets Fast Track Designation From FDA To Treat Chronic Hepatitis C
By: iStockAnalyst
Publish Date: Tuesday, May 15, 2012
Stocks(s): , ACHN

5-Star Buys From The 'Best On The Street'
By: TheStockAdvisors.com
Publish Date: Monday, May 14, 2012
Stocks(s): HUM, JCI, LVS, SPY, WIN

Potentially...Sharply Lower
By: Harry Boxer
Publish Date: Monday, May 14, 2012
Stocks(s): AAPL, AGEN, BMC, CMG, GS, IBM, IMOS, KERX

Johnson & Johnson (JNJ) Dividend Stock Analysis
By: Dividends4Life
Publish Date: Monday, May 14, 2012
Stocks(s): ABT, BMY, GPC, JNJ, LLY, MXM, NSC, TE

Opko Health (OPK) Gets U.S. Patent Allowance For Flow Control In Microfluidic Systems
By: iStockAnalyst
Publish Date: Monday, May 14, 2012
Stocks(s): OPK

Celsion (CLSN) Resubmits IND/IDE Application For Mid-Stage Study To Treat Bone Cancer
By: iStockAnalyst
Publish Date: Monday, May 14, 2012
Stocks(s): CLSN